JWM
NVCR icon

JPL Wealth Management’s NovoCure NVCR Stock Holding History

JPL Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88K Buy
+172
New +$2.15K ﹤0.01% 994

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

JPL Wealth Management's NVCR Position: Q1 2026 in Review

JPL Wealth Management opened a new position in NovoCure (NVCR) in Q1 2026: 172 shares worth $1.88K. The stake represents ﹤0.01% of the portfolio and ranks #994 among its holdings.

222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • JPL Wealth Management held 172 shares of NovoCure worth $1.88K as of Q1 2026.
  • NovoCure was a new JPL Wealth Management position in Q1 2026.
  • NovoCure made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #994 holding.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.